NCT01116895View on ClinicalTrials.gov

A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

July 31, 2011

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 22811

Oral solution

DRUG

Placebo

Placebo

Trial Locations (2)

G1V 4X7

Centre de Recherche Dermatologique du Quebec Metropolitain, Québec

Unknown

Hôpital Saint-Louis, Service de Dermatologie, Paris

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY